The rising incidence of liver disorders associated with metabolic syndromes has significantly increased the need for advanced therapeutic and diagnostic solutions worldwide. Non-alcoholic steatohepatitis (NASH), a progressive form of liver disease, is gaining attention due to its strong association with obesity, diabetes, and unhealthy lifestyles. Non-alcoholic Steatohepatitis Therapeutic &...